berotek and deoxycytidine
berotek has been researched along with deoxycytidine in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bernier, M; Singh, NS; Wainer, IW | 1 |
Other Studies
1 other study(ies) available for berotek and deoxycytidine
| Article | Year |
|---|---|
Selective GPR55 antagonism reduces chemoresistance in cancer cells.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B; beta Catenin; Biomarkers, Tumor; Carrier Proteins; Cell Proliferation; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Extracellular Signal-Regulated MAP Kinases; Fenoterol; Gemcitabine; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; MCF-7 Cells; Membrane Proteins; Mitogen-Activated Protein Kinase Kinases; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinase; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptors, Cannabinoid; Receptors, G-Protein-Coupled; Signal Transduction; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2016 |